Wound Closure and Advanced Wound Care Global Market - Forecast to 2023

Publishing Date : July, 2017
Report Code : HCMD 0125
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Wound closure and advanced wound care devices are used for the closure of the wound by pulling the cut edges of the tissues together or by directly acting on the wounds for better healing. Devices such as sutures, strips, sealants and adhesives, clips, staples, energy based devices, haemostats and skin grafts are used to minimize the trauma and infection leading to a better and a scar-free healing. The wound closure and advanced wound care global market is segmented based on the products, applications, end-users and geography. Products are divided into primary and secondary wound closure products. Primary wound closure devices include surgical sutures, wound closure strips, staples, ligating clips, haemostat, adhesives and sealants. Surgical suture market is segmented into suture and automated suturing device. Suture market is further divided based on types, filaments, and material type. Sealants are divided into natural and synthetic sealant. Natural sealants are collagen, fibrin and albumin. Synthetic sealants are divided into cyanoacrylate, polymer and others. Haemostats are divided into flowable haemostats, fibrin sealants, mechanical haemostats and active haemostats.

Secondary wound closure devices include energy based devices, therapy based devices, moist wound therapy and biologics. Energy based devices are divided into laser devices, electrical stimulations, electromagnetic stimulations, ultra sound therapy, radio frequency therapy and ultra violet therapy. Therapy based devices are further segmented into hyperbaric oxygen therapy, negative pressure wound therapy and pressure relief devices. Biologics are divided into skin grafts and growth factor. Moist wound therapy is segmented into film, foam, hydrocolloids, hydrogels, alginate and collagen dressings.

By application, the wound closure and advanced wound care markets are divided into burns, ulcers, surgical wounds, trauma and laceration and radionecrosis. Ulcers are further divided into pressure ulcers, arterial ulcers, venous leg ulcers and diabetic foot ulcers. Surgical wound are divided into general surgery, cardio vascular surgery, neuro and spine surgery, ENT surgery, orthopaedic surgery, urology surgery, oncology surgery, obstetrics and gynaecology surgery and plastics, cosmetics and reconstruction surgery. Based on the end- users market is segmented into hospitals, community healthcare services and home healthcare.

Among the wound closure and advanced wound care products, the primary wound closure market dominated the products market by occupying a largest share.  At the same time, secondary wound closure market is the fastest growing segment growing at high single digit CAGR from 2016 to 2023. In applications, the surgical wounds are the largest segment grand ulcers are the fastest growing segment with a high single digit CAGR 2016 to 2023. Among end- users, hospitals was the largest segment and also, the fastest growing segment growing at mid single digit from 2016 to 2023. Geography wise, North America is the largest market, followed by Europe and Asia. The APAC region is the fastest growing region growing at high single digit CAGR from 2016 to 2023 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the wound closure and advanced wound care market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases, aging population and government initiatives in establishing innovative technologies and demand for sophisticated medical services.

The wound closure and advanced wound care market is expected to grow steadily at a mid single digit CAGR from 2016 to 2023 to reach $25,268.9 million by 2023. The factors driving the growth of this market are increase in aging population and prevalence of lifestyle diseases, increase in surgical procedural volume, increase in prevalence of chronic wounds and government initiatives are some of the factors driving the wound closure and advanced wound care market. Demand for biologics, emergence of technically advanced products and acquisition to open an array of opportunities for market to flourish are some of the opportunities for wound closure and advanced wound care market. However, lack of trained professional in handling the sophisticated advanced wound care techniques, expensive sealants and glues impeding effective penetration in low and middle income countries are some of the factors hampering the market growth. The threats for the wound closure and advanced wound care market include unfavourable reimbursement policies in developing nations and stringent regulatory bodies guiding the wound closure and advanced wound care manufacturers.

 

The wound closure and advanced wound care global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the wound closure and advanced wound care market are Smith & Nephew (U.K.), Johnson and Johnson (U.S), Medtronic (Ireland), 3M healthcare (U.S), Acelity, Ltd. (U.S.), Coloplast (Denmark), C.R.Bard (U.S.), Baxter International (U.S.),Cardinal Health (U.S.), Integra life science (U.S.) and B. Braun Melsungen AG (Germany).

 

The report provides an in depth market analysis of the above mentioned segments across the following regions:

  • North America
  • Europe
  • Asia-Pacific 
  • Rest of the World (RoW) 
  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKE AWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET CRACKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     PRIMARY SOURCES
      • 2.5.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASE IN AGING POPULATION AND PREVALENCE OF LIFESTYLE DISEASES.
        • 3.3.1.2     INCREASE IN SURGICAL PROCEDURAL VOLUME
        • 3.3.1.3     INCREASING PREVALENCE OF CHRONIC WOUNDS
        • 3.3.1.4     GOVERNMENT INITIATIVES TO ENHANCE REACH OF HEALTHCARE FACILITIES
        • 3.3.1.5     EMERGENCE OF TECHNICALLY ADVANCED PRODUCTS
        • 3.3.1.6     DEMAND FOR BIOLOGICS
        • 3.3.1.7     ACQUISITIONS TO OPEN AN ARRAY OF OPPORTUNITIES FOR THE MARKET TO FLOURISH
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     LACK OF TRAINED PROFESSIONALS IN HANDLING THE SOPHISTICATED ADVANCED WOUND CLOSURE TECHNIQUES
        • 3.3.2.2     EXPENSIVE SEALANTS AND GLUES IMPEDING EFFECTIVE PENETRATION IN LOW AND MIDDLE INCOME COUNTRIES.
        • 3.3.2.3     UNFAVOURABLE REIMBURSEMENT POLICIES IN DEVELOPING NATIONS
        • 3.3.2.4     STRINGENT REGULATORY BODIES GUIDING THE WOUND CLOSURE AND ADVANCED WOUND CARE MANUFACTURERS
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     U.S.
      • 3.4.2     EUROPE
      • 3.4.3     INDIA
      • 3.4.4     CHINA
      • 3.4.5     JAPAN
    • 3.5     REIMBURSEMENT SCENARIO
      • 3.5.1     REIMBURSEMENT TABLE
        • 3.5.1.1     MASTOPEXY AND MAMMAPLASTY
        • 3.5.1.2     EXCISION BREAST LESION, LUMPECTOMY AND MASTECTOMY
        • 3.5.1.3     BREAST RECONSTRUCTIVE PROCEDURES
        • 3.5.1.4     CABG
        • 3.5.1.5     HEART VALVE REPLACEMENT AND REPAIR
        • 3.5.1.6     HIP AND KNEE REPLACEMENT
        • 3.5.1.7     ABDOMINOPLASTY
        • 3.5.1.8     STERNUM CLOSURE
        • 3.5.1.9     ROBOTIC ASSISTANCE
    • 3.6     TECHNOLOGICAL ADVANCEMENTS & ONGOING CLINICAL TRIALS
      • 3.6.1     NANOTECHNOLOGY WOUND CLOSURE
      • 3.6.2     SKIN SUBSTITUTES
      • 3.6.3     GENE THERAPY
      • 3.6.4     LOW LEVEL LASER THERAPY
      • 3.6.5     GROWTH FACTORS
      • 3.6.6     TOPCLOSURE 3S SYSTEM
      • 3.6.7     3D PRINTED SKIN FOR BURN WOUNDS
      • 3.6.8     RECELL
      • 3.6.9     SINGLE HAND SUTURING TECHNOLOGY
      • 3.6.10     BIOCHIPS FOR WOUND HEALING
      • 3.6.11     ONGOING CLINICAL TRIALS
    • 3.7     BIOMATERIALS
    • 3.8     PORTER’S FIVE FORCE ANALYSIS
      • 3.8.1     THREAT OF NEW ENTRANTS
      • 3.8.2     THREAT OF SUBSTITUTES
      • 3.8.3     RIVALRY AMONG EXISTING COMPETITORS
      • 3.8.4     BARGAINING POWER OF SUPPLIERS
      • 3.8.5     BARGAINING POWER OF BUYERS
    • 3.9     SUPPLY CHAIN ANALYSIS
    • 3.10     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
  • 4     WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET, BY PRODUCTS
    • 4.1     INTRODUCTION
    • 4.2     PRIMARY WOUND CLOSURE & ADVANCED WOUND CARE
      • 4.2.1     SURGICAL SUTURES
        • 4.2.1.1     SUTURES
          • 4.2.1.1.1     SUTURES, BY TYPE
            • 4.2.1.1.1.1     ABSORBABLE SUTURE
            • 4.2.1.1.1.2     NON-ABSORBABLE SUTURE
          • 4.2.1.1.2     SUTURE, BY MATERIAL TYPE
            • 4.2.1.1.2.1     NATURAL SUTURES
            • 4.2.1.1.2.2     SYNTHETIC SUTURES
        • 4.2.1.2     AUTOMATED SUTURING DEVICES
      • 4.2.2     WOUND CLOSURE STRIPS
      • 4.2.3     STAPLES
      • 4.2.4     LIGATING CLIPS
      • 4.2.5     ADHESIVES AND SEALANTS
        • 4.2.5.1     ADHESIVES
        • 4.2.5.2     SEALANTS
          • 4.2.5.2.1     NATURAL SEALANTS
            • 4.2.5.2.1.1     COLLAGEN BASED SEALANTS
            • 4.2.5.2.1.2     FIBRIN SEALANTS
            • 4.2.5.2.1.3     ALBUMIN BASED SEALANTS
          • 4.2.5.2.2     SYNTHETIC SEALANTS
            • 4.2.5.2.2.1     CYANOACRYLATE SEALANTS
            • 4.2.5.2.2.2     POLYMER BASED SEALANTS
            • 4.2.5.2.2.3     OTHER SEALANTS
      • 4.2.6     HAEMOSTATS
        • 4.2.6.1     FLOWABLE HAEMOSTATS
        • 4.2.6.2     FIBRIN HAEMOSTATS
        • 4.2.6.3     MECHANICAL HAEMOSTATS
        • 4.2.6.4     ACTIVE HAEMOSTATS
    • 4.3     SECONDARY WOUND CLOSURE & ADVANCED WOUND CARE
      • 4.3.1     BIOLOGICS
        • 4.3.1.1     SKIN GRAFTS
        • 4.3.1.2     GROWTH FACTORS
      • 4.3.2     THERAPY BASED DEVICES
        • 4.3.2.1     HYPERBARIC OXYGEN THERAPY DEVICE
        • 4.3.2.2     NEGATIVE PRESSURE WOUND THERAPY DEVICES
        • 4.3.2.3     PRESSURE RELIEF DEVICES
      • 4.3.3     ENERGY BASED DEVICES
      • 4.3.4     MOIST WOUND THERAPY
  • 5     WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET, BY APPLICATIONS
    • 5.1     INTRODUCTION
    • 5.2     BURNS
    • 5.3     ULCERS
      • 5.3.1     PRESSURE ULCERS
      • 5.3.2     VENOUS LEG ULCERS
      • 5.3.3     DIABETIC FOOT ULCERS
      • 5.3.4     ARTERIAL ULCERS
    • 5.4     SURGICAL WOUNDS
      • 5.4.1     GENERAL SURGERY
      • 5.4.2     UROLOGY SURGERY
      • 5.4.3     ORTHOPAEDIC SURGERY
      • 5.4.4     OBSTETRICS AND GYNAECOLOGY SURGERY
      • 5.4.5     PLASTICS, COSMETIC AND RECONSTRUCTION SURGERY
      • 5.4.6     ONCOLOGY
      • 5.4.7     CARDIOVASCULAR SURGERY
      • 5.4.8     NEURO AND SPINE SURGERY
      • 5.4.9     ENT SURGERY
    • 5.5     TRAUMA LACERATIONS
    • 5.6     RADIONECROSIS
  • 6     WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET, BY END-USERS
    • 6.1     INTRODUCTION
    • 6.2     HOSPITALS
    • 6.3     COMMUNITY HEALTH SERVICES
    • 6.4     HOME HEALTH CARE
  • 7     WOUND CLOSURE AND ADVANCED WOUND CARE MARKET, BY GEOGRAPHY
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     UNITED STATES (U.S.)
      • 7.2.2     OTHERS
    • 7.3     EUROPE
      • 7.3.1     U.K.
      • 7.3.2     ITALY
      • 7.3.3     GERMANY
      • 7.3.4     OTHERS
    • 7.4     ASIA-PACIFIC (APAC)
      • 7.4.1     INDIA
      • 7.4.2     CHINA
      • 7.4.3     JAPAN
      • 7.4.4     OTHERS
    • 7.5     REST OF WORLD (ROW)
      • 7.5.1     BRAZIL
      • 7.5.2     REST OF LATIN AMERICA
      • 7.5.3     MIDDLE EAST & OTHERS
  • 8     COMPANY DEVELOPMENTS
    • 8.1     INTRODUCTION
      • 8.1.1     PRODUCT LAUNCHES AS A MAJOR GROWTH STRATEGY OF WOUND CLOSURE & ADVANCED WOUND CARE MARKETPLAYERS
    • 8.2     NEW PRODUCT LAUNCH
    • 8.3     AGREEMENTS PARTERNER SHIPS, COLLABORATIONS & JOINT VENTURES
    • 8.4     MERGERS AND ACQUISITIONS
    • 8.5     APPROVAL
    • 8.6     OTHER DEVELOPMENTS
  • 9     COMPANY PROFILE
    • 9.1     3M
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     ACELITY LTD (ACELITY LTD & SYSTAGENIX)
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     BAXTER INTERNATIONAL, INC
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     B. BRAUN MELSUNGEN AG
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     PRODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     CARDINAL HEALTH INC.
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     C.R.BARD INC.
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     COLOPLAST
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     INTEGRA LIFESCIENCES CORPORATION
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     JOHNSON & JOHNSON (ETHICON)
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.10     MEDTRONIC, INC
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS
    • 9.11     SMITH & NEPHEW PLC
      • 9.11.1     OVERVIEW
      • 9.11.2     FINANCIALS
      • 9.11.3     PRODUCT PORTFOLIO
      • 9.11.4     KEY DEVELOPMENTS
      • 9.11.5     BUSINESS STRATEGY
      • 9.11.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 2     WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 3     WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 4     WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 5     WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 6     PRIMARY WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 7     PRIMARY WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 8     SURGICAL SUTURES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 9     SURGICAL SUTURES GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 10     SUTURES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 11     SUTURES GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 12     ABSORBABLE SUTURES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 13     NON-ABSORBABLE SUTURES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 14     AUTOMATED SUTURING DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 15     WOUND CLOSURE STRIPS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 16     STAPLES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 17     LIGATING CLIPS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 18     ADHESIVES & SEALANTS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 19     ADHESIVES & SEALANTS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 20     ADHESIVES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 21     SEALANTS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 22     SEALANTS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 23     NATURAL SEALANTS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 24     NATURAL SEALANTS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 25     COLLAGEN BASED SEALANTS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 26     FIBRIN SEALANTS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 27     ALBUMIN BASED SEALANTS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 28     SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 29     SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 30     CYANOACRYLATE SEALANTS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 31     POLYMER BASED SEALANTS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 32     OTHER SEALANTS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 33     HAEMOSTATS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 34     HAEMOSTATS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 35     FLOWABLE HAEMOSTATS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 36     FIBRIN HAEMOSTATS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 37     MECHANICAL HAEMOSTATS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 38     ACTIVE HAEMOSTATS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 39     SECONDARY WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 40     SECONDARY WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 41     BIOLOGICS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 42     BIOLOGICS GLOBAL MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 43     SKIN GRAFTS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 44     GROWTH FACTORS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 45     THERAPY BASED DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 46     THERAPY BASED DEVICES GLOBAL MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 47     HYPERBARIC OXYGEN THERAPY DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 48     NEGATIVE PRESSURE WOUND THERAPY DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 49     PRESSURE RELIEF DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 50     ENERGY BASED DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 51     MOIST WOUND THERAPY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 52     WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 53     BURNS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 54     ULCERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 55     ULCERS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 56     PRESSURE ULCERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 57     VENOUS LEG ULCERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 58     DIABETIC FOOT ULCERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 59     ARTERIAL ULCERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 60     SURGICAL WOUNDS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 61     SURGICAL WOUNDS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 62     GENERAL SURGERY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 63     UROLOGY SURGERY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 64     ORTHOPAEDIC SURGERY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 65     OBSTETRICS & GYNAECOLOGY SURGERY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 66     PLASTICS, COSMETICS & RECONSTRUCTION SURGERY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 67     ONCOLOGY SURGERY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 68     CARDIOVASCULAR SURGERY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 69     NEURO & SPINE SURGERY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 70     ENT SURGERY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 71     TRAUMA LACERATIONS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 72     RADIONECROSIS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 73     WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 74     HOSPITALS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 75     COMMUNITY HEALTH SERVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 76     HOME HEALTHCARE GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 77     NORTH AMERICAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 78     NORTH AMERICAN PRIMARY WOUND CLOSURE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 79     NORTH AMERICAN SURGICAL SUTURES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 80     NORTH AMERICAN SUTURES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 81     NORTH AMERICAN ADHESIVES & SEALANTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 82     NORTH AMERICAN SEALANTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 83     NORTH AMERICAN NATURAL SEALANTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 84     NORTH AMERICAN SYNTHETIC SEALANTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 85     NORTH AMERICAN HAEMOSTATS MARKET REVENUE, BY TYPE,(2015-2023) ($MN)
      • TABLE 86     NORTH AMERICAN SECONDARY WOUND CLOSURE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 87     NORTH AMERICAN THERAPY BASED DEVICES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 88     NORTH AMERICAN BIOLOGICS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 89     NORTH AMERICAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY APPLICATIONS,(2015-2023) ($MN)
      • TABLE 90     NORTH AMERICAN ULCERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 91     NORTH AMERICAN SURGICAL WOUNDS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 92     NORTH AMERICAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 93     EUROPEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 94     EUROPEAN PRIMARY WOUND CLOSURE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 95     EUROPEAN SURGICAL SUTURES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 96     EUROPEAN SUTURES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 97     EUROPEAN ADHESIVES & SEALANTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 98     EUROPEAN SEALANTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 99     EUROPEAN NATURAL SEALANTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 100     EUROPEAN SYNTHETIC SEALANTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 101     EUROPEAN HAEMOSTATS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 102     EUROPEAN SECONDARY WOUND CLOSURE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 103     EUROPEAN THERAPY BASED DEVICES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 104     EUROPEAN BIOLOGICS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 105     EUROPEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 106     EUROPEAN ULCERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 107     EUROPEAN SURGICAL WOUNDS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 108     EUROPEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 109     APAC WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 110     APAC PRIMARY WOUND CLOSURE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 111     APAC SURGICAL SUTURES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 112     APAC SUTURES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 113     APAC ADHESIVES & SEALANTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 114     APAC SEALANTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 115     APAC NATURAL SEALANTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 116     APAC SYNTHETIC SEALANTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 117     APAC HAEMOSTATS MARKET REVENUE, BY TPE, (2015-2023) ($MN)
      • TABLE 118     APAC SECONDARY WOUND CLOSURE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 119     APAC THERAPY BASED DEVICES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 120     APAC BIOLOGICS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 121     APAC WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 122     APAC ULCERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 123     APAC SURGICAL WOUNDS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 124     APAC WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 125     ROW WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 126     ROW PRIMARY WOUND CLOSURE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 127     ROW SURGICAL SUTURES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 128     ROW SUTURES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 129     ROW ADHESIVES & SEALANTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 130     ROW SEALANTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 131     ROW NATURAL SEALANTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 132     ROW SYNTHETIC SEALANTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 133     ROW HAEMOSTATS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 134     ROW SECONDARY WOUND CLOSURE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 135     ROW THERAPY BASED DEVICES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 136     ROW BIOLOGICS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 137     ROW WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 138     ROW ULCERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 139     ROW SURGICAL WOUNDS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 140     ROW WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 141     NEW PRODUCT LAUNCHES (2016-2017)
      • TABLE 142     AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2015-2017)
      • TABLE 143     MERGERS AND ACQUITIONS (2015)
      • TABLE 144     APPROVALS (2015-2017)
      • TABLE 145     OTHER DEVELOPMENTS (2016)
      • TABLE 146     3M: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 147     3M: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 148     3M: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 149     ACELITY LTD: TOTAL REVENUE AND R&D EXPENSES, (2014-2016*) ($MN)
      • TABLE 150     ACELITY LTD : TOTAL REVENUE, BY SEGMENTS, (2014-2016*) ($MN)
      • TABLE 151     ACELITY LTD : TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 152     BAXTER INTERNATIONAL, INC.: TOTAL SALES AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 153     BAXTER INTERNATIONAL, INC.: TOTAL SALES, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 154     BAXTER INTERNATIONAL, INC.: TOTAL SALES, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 155     B BRAUN MELSUNGEN: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
      • TABLE 156     B BRAUN MELSUNGEN: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 157     B BRAUN MELSUNGEN: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 158     CARDINAL HEALTH, INC.: TOTAL REVENUE AND OPERATING EXPENSES (2015-2017*) ($MN)
      • TABLE 159     CARDINAL HEALTH, INC.: TOTAL REVENUE, BY SEGMENT, (2015-2017*) ($MN)
      • TABLE 160     CARDINAL HEALTH, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 161     C.R.BARD INC.: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 162     C.R.BARD INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 163     COLOPLAST: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 164     COLOPLAST: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 165     COLOPLAST: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 166     INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 167     INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 168     INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 169     JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 170     JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 171     JOHNSON & JOHNSON: TOTAL REVENUE, BY MEDICAL DEVICE SEGMENTS, (2014-2016) ($MN)
      • TABLE 172     JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 173     MEDTRONIC INC.: TOTAL REVENUE AND R&D EXPENSES, (2015-2017*) ($MN)
      • TABLE 174     MEDTRONIC INC.: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 175     MEDTRONIC INC.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 176     SMITH & NEPHEW PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 177     SMITH & NEPHEW PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 178     SMITH & NEPHEW PLC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)

      LIST OF FIGURES

      • FIGURE 1     WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET SHARE, BY GEOGRAPHY, (2015-2023) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: WOUND CLOSURE & ADVANCED WOUND CARE MARKET
      • FIGURE 3     WOUND CLOSURE & ADVANCED WOUND CARE MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     WOUND CLOSURE & ADVANCED WOUND CARE MARKET:FORECASTING MODEL
      • FIGURE 5     WOUND CLOSURE & ADVANCED WOUND CARE MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
      • FIGURE 6     WOUND CLOSURE & ADVANCED WOUND CARE MARKET: MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     WOUND CLOSURE & ADVANCED WOUND CARE MARKET: PORTER’S ANALYSIS
      • FIGURE 9     WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
      • FIGURE 11     WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY PRODUCTS, (2016 V’S 2023) ($MN)
      • FIGURE 12     PRIMARY WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY TYPE, (2016 V'S 2023) ($MN)
      • FIGURE 13     SURGICAL SUTURES GLOBAL MARKET REVENUE, BY TYPE, (2016 V'S 2023) ($MN)
      • FIGURE 14     SUTURES GLOBAL MARKET REVENUE, BY TYPE, (2016 V'S 2023) ($MN)
      • FIGURE 15     ADHESIVES & SEALANTS GLOBAL MARKET REVENUE, BY TYPE, (2016 V'S 2023) ($MN)
      • FIGURE 16     SEALANTS GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 17     NATURAL SEALANTS GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 18     SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 19     HAEMOSTATS GLOBAL MARKET SIZE, BY TYPE, (2016 V’S 2023) ($ MN)
      • FIGURE 20     SECONDARY WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 21     BIOLOGICS GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 22     THERAPY BASED DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 23     WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET SHARE, BY APPLICATIONS, (2016) (%)
      • FIGURE 24     ULCERS GLOBAL MARKET SHARE, BY TYPE, (2016) (%)
      • FIGURE 25     SURGICAL WOUND APPLICATIONS GLOBAL MARKET SHARE, BY THERAPEUTIC AREA, (2016) (%)
      • FIGURE 26     WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET SHARE, BY END-USER, (2016 V’S 2023) (%)
      • FIGURE 27     WOUND CLOSURE & ADVANCED WOUND CARE GLOBAL MARKET SCENARIO BY REGION, (2015-2023) ($MN) CAGR (%)
      • FIGURE 28     NORTH AMERICAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, END-USERS & APPLICATIONS (2016 V’S 2023) ($MN)
      • FIGURE 29     NORTH AMERICAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SHARE, BY COUNTRY, (2016) (%)
      • FIGURE 30     NORTH AMERICAN PRIMARY WOUND CLOSURE MARKET SHARE, BY TYPE, (2016 V’S 2023) (%)
      • FIGURE 31     NORTH AMERICAN SECONDARY WOUND CLOSURE MARKET SHARE, BY TYPE, (2016 V’S 2023) (%)
      • FIGURE 32     NORTH AMERICAN ULCERS MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 33     NORTH AMERICAN SURGICAL WOUNDS MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 34     U.S. WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, END-USERS & APPLICATIONS (2016 V’S 2023) ($MN)
      • FIGURE 35     OTHERS WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, END-USERS & APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 36     EUROPEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, END-USERS & APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 37     EUROPEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SHARE, BY COUNTRY, (2016) (%)
      • FIGURE 38     EUROPEAN PRIMARY WOUND CLOSURE MARKET SHARE, BY TYPE, (2016 V’S 2023) (%)
      • FIGURE 39     EUROPEAN SECONDARY WOUND CLOSURE MARKET SHARE, BY TYPE, (2016 V’S 2023) (%)
      • FIGURE 40     EUROPEAN ULCERS MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 41     EUROPEAN SURGICAL WOUNDS MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 42     UK WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, END-USERS & APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 43     ITALY WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, END-USERS & APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 44     GERMANY WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, END-USERS & APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 45     OTHERS WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, END-USERS & APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 46     APAC WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, END-USERS & APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 47     APAC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SHARE, BY COUNTRY, (2016 V’S 2023) (%)
      • FIGURE 48     APAC PRIMARY WOUND CLOSURE MARKET SHARE, BY TYPE, (2016 V’S 2023) (%)
      • FIGURE 49     APAC SECONDARY WOUND CLOSURE MARKET SHARE, BY TYPE, (2016 V’S 2023) (%)
      • FIGURE 50     APAC ULCERS MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 51     APAC SURGICAL WOUNDS MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 52     INDIAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, END-USERS & APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 53     CHINA WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, END-USERS & APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 54     JAPAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, END-USERS & APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 55     OTHERS WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, END-USERS & APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 56     ROW WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, END-USERS & APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 57     ROW WOUND CLOSURE & ADVANCED WOUND CARE MARKET SHARE, BY COUNTRY, (2016) (%)
      • FIGURE 58     ROW PRIMARY WOUND CLOSURE MARKET SHARE, BY TYPE, (2016 V’S 2023) (%)
      • FIGURE 59     ROW SECONDARY WOUND CLOSURE MARKET SHARE, BY TYPE, (2016 V’S 2023) (%)
      • FIGURE 60     ROW ULCERS MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 61     ROW SURGICAL WOUNDS MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 62     BRAZIL WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, END-USERS & APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 63     REST OF LATAM WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, END-USERS & APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 64     MIDDLE EAST & OTHERS WOUND CLOSURE & ADVANCED WOUND CARE MARKET REVENUE, BY BY PRODUCTS, END-USERS & APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 65     KEY GROWTH STRATEGIES (2015-2017)
      • FIGURE 66     SWOT: 3M
      • FIGURE 67     SWOT: ACELITY, LTD
      • FIGURE 68     SWOT: BAXTER INTERNATIONAL, INC.
      • FIGURE 69     SWOT ANALYSIS: B.BRAUN MELSUNGEN AG
      • FIGURE 70     SWOT: CARDINAL HEALTH, INC.
      • FIGURE 71     SWOT : C.R.BARD INC.
      • FIGURE 72     SWOT: COLOPLAST
      • FIGURE 73     SWOT: INTEGRA LIFESCIECES CORPORATION
      • FIGURE 74     SWOT: JOHNSON & JOHNSON
      • FIGURE 75     SWOT: MEDTRONIC, INC
      • FIGURE 76     SWOT: SMITH & NEPHEW PLC

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     3M
      • 2     ACELITY LTD
      • 3     ACKERMANN INSTRUMENTE GMBH
      • 4     AD SURGICAL
      • 5     ADHESIVE RESEARCH, INC.
      • 6     ADHEZION BIOMEDICAL
      • 7     ADVANCED BIOHEALING
      • 8     ADVANCED MEDICAL SOLUTIONS GROUP PLC
      • 9     AEDICELL, INC.
      • 10     AEROBELLA MEDICAL, LLC
      • 11     ALLIQUA BIOMEDICAL
      • 12     ANGELINI PHARMA, INC.
      • 13     ANODYHE THERAPY LLC
      • 14     APOLLO ENDOSURGERY
      • 15     APPLIED MEDICAL RESOURCES CORPORATION
      • 16     ARJOHUNHEIGH
      • 17     ASSUT MEDICAL SARL 
      • 18     ATMOS MEDIZIN TECHNIK
      • 19     ATROMAT
      • 20     B.BRAUN MELSUNGEN
      • 21     BAXTER INTERNATIONAL
      • 22     BEIERSDORF
      • 23     BIOELECTRONICS
      • 24     BRISTOL-MYERS SQUIBB
      • 25     BSN MEDICAL
      • 26     C.R.BARD
      • 27     CARDINAL HEALTH, INC
      • 28     CHEMENCE
      • 29     CLINISUT
      • 30     COHERA MEDICALS
      • 31     COHESION TECHNOLOGIES
      • 32     COLOPLAST
      • 33     CONMED
      • 34     CONVATEC
      • 35     CORDIS CORPORATION
      • 36     CP MEDICAL
      • 37     CRYOLIFE INC
      • 38     DE ROYAL
      • 39     DEMETECH
      • 40     DENTSPLY LIMITED
      • 41     DERMA SCIENCES
      • 42     DIAPULSE CORPORATION OF AMERICA
      • 43     DOGSAN
      • 44     DOLPHIN SUTURES
      • 45     DUKAL CORPORATION
      • 46     DYNASIL CORPORATION OF AMERICA
      • 47     DYNEK
      • 48     ENDO EVOLUTION
      • 49     ETC BIOMEDICAL SYSTEM
      • 50     FINE SURGICAL
      • 51     FLINK ENGINEERING PTY LTD
      • 52     FUTURA SURGICARE PVT LTD
      • 53     GELITA MEDICAL
      • 54     GEM ITALY
      • 55     GETINGE GROUP (MAQUET)
      • 56     GLUSTITCH INC
      • 57     GRENA LTD
      • 58     GULF COAST HYPERBARIC, INC.
      • 59     HAEMACURE CORPORATION
      • 60     HALYARD HEALTH
      • 61     HEALTHPOINT BIOTHERAPEUTICS LTD
      • 62     HLA LIFECARE LTD
      • 63     HOLLISTER
      • 64     HOLYCON
      • 65     HYPERBRANCH MEDICAL TECHNOLOGY
      • 66     IHC HYTECH B.V.
      • 67     INCISIVE SURGICAL, INC.
      • 68     INTEGRA LIFESCIENCES
      • 69     INTERNACIONAL FARMACÉUTICA
      • 70     INTERPORE CROSS INTERNATIONAL, INC.
      • 71     INVACARE CORPORATION
      • 72     JOHNSON & JOHNSON
      • 73     KATECHO INC
      • 74     KERECIS
      • 75     KONO SEISAKUSHO
      • 76     LASER NEEDLE
      • 77     LIFEBOND 
      • 78     LIFENET HEALTH, INC.
      • 79     LOHMANN & RAUSCHER GMBH & CO. KG
      • 80     LSI SOLUTIONS
      • 81     MANI, INC
      • 82     MEDICHOICE
      • 83     MEDLINE INDUSTRIES
      • 84     MEDTRONIC INC
      • 85     MEYER-HAAKE
      • 86     MOLYNLYCKE HEALTHCARE
      • 87     NUO THERAPEUTICS
      • 88     OCULAR THERAPEUTICS
      • 89     ORGANOGENESIS
      • 90     ORTHOVITA INC
      • 91     OXYHEAL HEALTH GROUP
      • 92     PAUL HARTMANN
      • 93     PETERS SURGICAL
      • 94     PROSPERA TECHNOLOGIES LLC
      • 95     PROTEIN POLYMER TECHNOLOGIES, INC. 
      • 96     PURPLE SURGICALS
      • 97     QINGDAO KINGSTON MEDICAL DEVICES CO.
      • 98     RIVERPOINT MEDICAL
      • 99     SAMYANG BIOPHARMACEUTICALS
      • 100     SEALANTIS
      • 101     SECHRIST INDUSTRIES, INC.
      • 102     SHANGHAI TIANQING 
      • 103     SHANXIAN HUAYU SUTURE MATERIALS CO., LTD.
      • 104     SMB CORPORATION OF INDIA
      • 105     SMI SUTURES
      • 106     SMITH & NEPHEW
      • 107     SORING GMBH
      • 108     SOS MEDICAL GROUP
      • 109     SOUTHINGTON TOOL & MANUFACTURING CORP
      • 110     SPIRACUR, INC.
      • 111     STRATATECH CORPORATION
      • 112     STRYKER CORPORATION
      • 113     SURGICAL SPECIALTIES CORPORATION
      • 114     SURGIFORM TECHNOLOGY LTD
      • 115     SUTURE
      • 116     SWEDEN & MARTINA SPA
      • 117     TAIWAN SURGICALS
      • 118     TANAXIZ MEDICAL
      • 119     TECHNO-GAZ
      • 120     TEI BIOSCIENCES INC
      • 121     TEKNIMED CORPORATION
      • 122     TELEFLEX MEDICAL
      • 123     THE MEDICINE COMPANY
      • 124     THERMO GENESIS CORP
      • 125     THOR LASER
      • 126     TISSUESEAL
      • 127     UNIK SURGICAL SUTURES MFG
      • 128     UNITED MEDICAL 
      • 129     URGO MEDICAL
      • 130     VESOCCLUDE MEDICAL LLC
      • 131     VIGILENZ
      • 132     VINGMED
      • 133     VIROMED CO., LTD
      • 134     VIVOSTAT A/S
      • 135     VOMARIS WOUND CARE
      • 136     W.L. GORE & ASSOCIATES
      • 137     WELFARE MEDICLES
      • 138     WOUND CARE TECHNOLOGIES
      • 139     WUTTAN VSO MEDICAL SCIENCE & TECHNOLOGY CO
      • 140     WUXI BIOT BIOLOGY TECHNOLOGY CO., LTD
      • 141     YAFHO WOUND CARE
      • 142     ZHEJIANG AOKI MEDICAL DRESSING CO. LTD
      • 143     ZIMMER HOLDINGS
      • 144     ZYMOGENETICS INC